(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n ³Ô¹Ï±¬ÁÏ\u306e\u5275\u696d\u8005\u517cCEO\u3067\u3042\u308bPeter Gassner\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c³Ô¹Ï±¬ÁÏ\u304c\u76ee\u6307\u3057\u3066\u3044\u308b\u306e\u306f\u3001\u8a66\u9a13\u306e\u5b9f\u65bd\u3092\u7c21\u7d20\u5316\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u304c\u81e8\u5e8a\u7814\u7a76\u3068\u60a3\u8005\u30b1\u30a2\u3068\u3044\u3046\u91cd\u8981\u306a\u696d\u52d9\u306b\u96c6\u4e2d\u3067\u304d\u308b\u3088\u3046\u652f\u63f4\u3059\u308b\u3053\u3068\u3067\u3059\u3002\u5f53\u793e\u306f\u3001\u81e8\u5e8a\u7814\u7a76\u30b3\u30df\u30e5\u30cb\u30c6\u30a3\u3068\u9023\u643a\u3057\u3066\u3001\u5927\u5207\u306a\u533b\u85ac\u54c1\u3092\u5fc5\u8981\u3068\u3057\u3066\u3044\u308b\u60a3\u8005\u69d8\u306b\u304a\u5c4a\u3051\u3059\u308b\u305f\u3081\u306e\u30d7\u30ed\u30bb\u30b9\u3092\u7c21\u7d20\u5316\u3057\u3001\u8fc5\u901f\u5316\u3059\u308b\u305f\u3081\u306e\u304a\u624b\u4f1d\u3044\u304c\u3067\u304d\u308b\u3053\u3068\u3092\u8a87\u308a\u306b\u601d\u3063\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n ³Ô¹Ï±¬ÁÏ SiteVault\u306f\u3001\u96fb\u5b50\u7f72\u540d\u3001\u30ea\u30e2\u30fc\u30c8\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3001Certified Copy (\u4fdd\u8a3c\u4ed8\u304d\u8907\u5199\uff09\u306b\u5fdc\u3058\u305f\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u3001\u30ec\u30dd\u30fc\u30c6\u30a3\u30f3\u30b0\u306a\u3069\u306e\u6a5f\u80fd\u3092\u63d0\u4f9b\u3057\u3001\u85ac\u4e8b\u95a2\u9023\u306e\u6587\u66f8\u3084\u30d7\u30ed\u30bb\u30b9\u306e\u7ba1\u7406\u306b\u304a\u3051\u308b\u8ca0\u62c5\u3092\u6e1b\u3089\u3057\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ SiteVault\u306f\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u304c\u5229\u7528\u3057\u3066\u3044\u308b\u30b7\u30b9\u30c6\u30e0\u306b\u304b\u304b\u308f\u3089\u305a\u3001\u3042\u3089\u3086\u308b\u8a66\u9a13\u306b\u4f7f\u7528\u3067\u304d\u307e\u3059\u3002\u307e\u305f\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306b\u304a\u3051\u308b\u533b\u5e2b\u4e3b\u5c0e\u578b\u306e\u6cbb\u9a13\u7528\u30d5\u30a1\u30a4\u30eb\u306b\u3082\u4f7f\u7528\u3067\u304d\u307e\u3059\u3002SiteVault Free\u304a\u3088\u3073SiteVault Enterprise\u306e\u3044\u305a\u308c\u3082\u300121 CFR Part 11\u304a\u3088\u3073HIPAA\u306e\u8981\u4ef6\u3092\u6e80\u305f\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n SiteVault Free\u306e\u30e6\u30fc\u30b6\u30fc\u6570\u306b\u5236\u9650\u306f\u306a\u304f\u3001³Ô¹Ï±¬ÁÏ\u306e\u30d5\u30eb\u30ab\u30b9\u30bf\u30de\u30fc\u30b5\u30dd\u30fc\u30c8\u3082\u5229\u7528\u3067\u304d\u307e\u3059\u30022019\u5e7412\u6708\u306e\u63d0\u4f9b\u958b\u59cb\u3092\u4e88\u5b9a\u3057\u3066\u304a\u308a\u3001sites.veeva.com<\/a>\u306b\u3066\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306b\u3088\u308bSiteVault Free\u306e\u30ea\u30ea\u30fc\u30b9\u524d\u306e\u4e8b\u524d\u767b\u9332\u304c\u53ef\u80fd\u3067\u3059\u3002<\/p>\n <\/p>\n SiteVault Enterprise\u306f\u3001³Ô¹Ï±¬ÁÏ SiteVault\u306e\u8a2d\u5b9a\u5909\u66f4\u304c\u53ef\u80fd\u306a\u30a8\u30c7\u30a3\u30b7\u30e7\u30f3\u3067\u3042\u308a\u3001\u7d71\u5408\u7528\u306e\u30aa\u30fc\u30d7\u30f3API\u3001\u30ab\u30b9\u30bf\u30de\u30a4\u30ba\u3055\u308c\u305f\u30ec\u30dd\u30fc\u30c8\u3001\u7528\u9014\u306b\u5fdc\u3058\u305f\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u3092\u5099\u3048\u3066\u3044\u307e\u3059\u3002SiteVault Enterprise\u306f\u63d0\u4f9b\u958b\u59cb\u3055\u308c\u3066\u304a\u308a\u3001\u65e2\u306bIACT Health\u3001Ora, Inc.\u3001Penn Medicine\u3001Louisville\u5927\u5b66\u306a\u3069\u306e\u8457\u540d\u306a\u7814\u7a76\u6a5f\u95a2\u3067\u5c0e\u5165\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u30b7\u30b9\u30c6\u30e0<\/a>\u306e\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30d7\u30ed\u30d0\u30a4\u30c0\u30fc\u3067\u3042\u308a\u3001Vault eTMF<\/a>\u3068Vault Study Startup<\/a>\u306f\u3001\u4e16\u754c\u306e\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u4e0a\u4f4d20\u793e\u306e\u3046\u306112\u793e\u3092\u542b\u3080\u3001200\u4ee5\u4e0a\u306e\u30b9\u30dd\u30f3\u30b5\u30fc\u304c\u5c0e\u5165\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f2020\u5e74\u4e0b\u534a\u671f\u306b\u3001³Ô¹Ï±¬ÁÏ SiteVault\u3092\u4f7f\u7528\u3057\u3066\u3044\u308b\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u304b\u3089Vault eTMF\u307e\u305f\u306fVault Study Startup\u3092\u4f7f\u7528\u3057\u3066\u3044\u308b\u30b9\u30dd\u30f3\u30b5\u30fc\u3078\u3001\u6587\u66f8\u3084\u30c7\u30fc\u30bf\u3092\u81ea\u52d5\u5171\u6709\u3067\u304d\u308b\u3088\u3046\u306b\u3059\u308b\u4e88\u5b9a\u3067\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ SiteVault<\/strong>\u306b\u3064\u3044\u3066\u306e\u696d\u754c\u306e\u8a55\u4fa1:<\/strong><\/p>\n Society for Clinical Research Sites\uff08SCRS\uff09\u306e\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bCasey Orvin\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cSCRS\u3067\u306f\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306b\u5bfe\u3059\u308b\u624b\u539a\u3044³Ô¹Ï±¬ÁÏ\u306e\u30a2\u30d7\u30ed\u30fc\u30c1\u3092\u9ad8\u304f\u8a55\u4fa1\u3057\u3066\u3044\u307e\u3059\u3002\u533b\u7642\u6a5f\u95a2\u306e\u8996\u70b9\u306b\u7acb\u3063\u3066\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3092\u8a2d\u8a08\u3059\u308b\u3053\u3068\u304c\u3001\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u30d7\u30ed\u30d0\u30a4\u30c0\u30fc\u306b\u3068\u3063\u3066\u306f\u5927\u304d\u306a\u30c1\u30e3\u30f3\u30b9\u3068\u306a\u308b\u306f\u305a\u3067\u3059\u3002\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306b\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u30cb\u30fc\u30ba\u3092\u53cd\u6620\u3055\u305b\u308c\u3070\u3001\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u30d7\u30ed\u30bb\u30b9\u306e\u5408\u7406\u5316\u3068\u3044\u3046\u76ee\u6a19\u3092\u3088\u308a\u52b9\u679c\u7684\u306b\u9054\u6210\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308b\u3067\u3057\u3087\u3046\u3002\u300d<\/p>\n AstraZeneca\u793e\u306e\u958b\u767a\u696d\u52d9\u62c5\u5f53\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3042\u308bDoug Schantz\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u304c\u5f93\u6765\u3068\u306f\u7570\u306a\u308b\u8003\u3048\u65b9\u3067\u81e8\u5e8a\u7814\u7a76\u6a5f\u95a2\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u3092\u30b5\u30dd\u30fc\u30c8\u3067\u304d\u308b\u3088\u3046\u652f\u63f4\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ SiteVault Free\u306f\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u304c\u5e45\u5e83\u304f\u4f7f\u7528\u3057\u3066\u3044\u308b³Ô¹Ï±¬ÁÏ Vault\u3068\u540c\u3058\u30b7\u30b9\u30c6\u30e0\u3067\u3001\u3042\u3089\u3086\u308b\u30bf\u30a4\u30d7\u306e\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3067\u696d\u52d9\u3092\u6a19\u6e96\u5316\u3067\u304d\u307e\u3059\u3002\u300d<\/p>\n \u30c8\u30c3\u30d7\u30ec\u30d9\u30eb\u306e\u5b66\u8853\u7814\u7a76\u6a5f\u95a2\u3067\u3042\u308bLouisville\u5927\u5b66\u3067\u81e8\u5e8a\u8a66\u9a13\u30e6\u30cb\u30c3\u30c8\u62c5\u5f53\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3092\u52d9\u3081\u308bLale Akca\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u3053\u308c\u306f\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3068\u30b9\u30dd\u30f3\u30b5\u30fc\u304c\u81e8\u5e8a\u8a66\u9a13\u5168\u4f53\u3092\u901a\u3058\u3066\u9023\u643a\u3057\u3001\u60c5\u5831\u5171\u6709\u306e\u65b9\u6cd5\u3092\u6539\u5584\u3067\u304d\u308b\u5927\u304d\u306a\u30c1\u30e3\u30f3\u30b9\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ SiteVault Enterprise\u306f\u3001\u5927\u898f\u6a21\u306a\u81e8\u5e8a\u7814\u7a76\u6a5f\u69cb\u3067\u306e\u8907\u96d1\u306a\u7814\u7a76\u696d\u52d9\u3092\u652f\u63f4\u3057\u3001\u8a66\u9a13\u306e\u5b9f\u65bd\u3092\u8fc5\u901f\u5316\u3067\u304d\u308b\u3088\u3046\u306b\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u304f\u308c\u308b\u67d4\u8edf\u306a\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u3059\u3002\u300d<\/p>\n <\/p>\n \u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Forward-looking Statements\u3011<\/strong> 2019\u5e7410\u670816\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b …<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-42992","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42992"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=42992"}],"version-history":[{"count":3,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42992\/revisions"}],"predecessor-version":[{"id":42997,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42992\/revisions\/42997"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=42992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=42992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=42992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"\"](\"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2019\/10\/³Ô¹Ï±¬ÁÏ-SiteVault_191003-e1571191523176.jpg\")
\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067775\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-K for the period ended July 31, 2019. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"